MedTrace Logo

Discure Technologies Feasibility Study for DDD

NCT06127745 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2023-11-14

No results posted yet for this study

Summary

The objective of this study is to evaluate the safety and performance of the Discure System therapy in subjects with early to moderate degeneration of the disc (DDD).

Conditions

  • Degenerative Disc Disease
  • Chronic Low-back Pain
  • Discogenic Pain

Interventions

DEVICE

Discure System

All subjects enrolled into the study will be implanted with the Discure System in a minimally invasive procedure.

Sponsors & Collaborators

  • Discure Technologies Ltd.

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
22 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-01-31
Primary Completion
2024-11-30
Completion
2024-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06127745 on ClinicalTrials.gov